Quadrant Capital Group’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,344
| Closed | -$15.5K | – | 2019 |
|
|
2025
Q1 | $15.5K | Buy |
2,344
+714
| +44% | +$4.71K | ﹤0.01% | 2111 |
|
|
2024
Q4 | $14.2K | Sell |
1,630
-60
| -4% | -$523 | ﹤0.01% | 2017 |
|
|
2024
Q3 | $33K | Sell |
1,690
-7
| -0.4% | -$137 | ﹤0.01% | 1672 |
|
|
2024
Q2 | $34.9K | Sell |
1,697
-62
| -4% | -$1.28K | ﹤0.01% | 1588 |
|
|
2024
Q1 | $37.5K | Buy |
1,759
+69
| +4% | +$1.47K | ﹤0.01% | 1548 |
|
|
2023
Q4 | $24.3K | Buy |
1,690
+1,642
| +3,421% | +$23.6K | ﹤0.01% | 1724 |
|
|
2023
Q3 | $438 | Buy |
48
+30
| +167% | +$274 | ﹤0.01% | 2587 |
|
|
2023
Q2 | $191 | Sell |
18
-1,369
| -99% | -$14.5K | ﹤0.01% | 2658 |
|
|
2023
Q1 | $17K | Buy |
+1,387
| New | +$17K | ﹤0.01% | 1781 |
|
|
2022
Q3 | – | Sell |
-52
| Closed | -$1K | – | 2726 |
|
|
2022
Q2 | $1K | Sell |
52
-9
| -15% | -$173 | ﹤0.01% | 2390 |
|
|
2022
Q1 | $1K | Buy |
+61
| New | +$1K | ﹤0.01% | 2330 |
|
|
2020
Q2 | – | Sell |
-16
| Closed | – | – | 2315 |
|
|
2020
Q1 | $0 | Buy |
+16
| New | – | ﹤0.01% | 2186 |
|